# A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

> **NCT06443684** · — · RECRUITING · sponsor: **Shanghai Chest Hospital** · enrollment: 305 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** MRD

## Key facts

- **NCT ID:** NCT06443684
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-08
- **Primary completion:** 2025-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 305 (ESTIMATED)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06443684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06443684, "A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06443684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*